Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.

Both J, Wu T, Bras J, Schaap GR, Baas F, Hulsebos TJ.

PLoS One. 2012;7(1):e30907. doi: 10.1371/journal.pone.0030907. Epub 2012 Jan 26.

2.

Overexpression through amplification of genes in chromosome region 17p11.2 approximately p12 in high-grade osteosarcoma.

van Dartel M, Redeker S, Bras J, Kool M, Hulsebos TJ.

Cancer Genet Cytogenet. 2004 Jul 1;152(1):8-14.

PMID:
15193436
3.

Amplification and overexpression of genes in 17p11.2 ~ p12 in osteosarcoma.

van Dartel M, Hulsebos TJ.

Cancer Genet Cytogenet. 2004 Aug;153(1):77-80. Review.

PMID:
15325100
4.

Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma.

van Dartel M, Cornelissen PW, Redeker S, Tarkkanen M, Knuutila S, Hogendoorn PC, Westerveld A, Gomes I, Bras J, Hulsebos TJ.

Cancer Genet Cytogenet. 2002 Dec;139(2):91-6.

PMID:
12550767
5.

Oncogenic Properties of Candidate Oncogenes in Chromosome Region 17p11.2p12 in Human Osteosarcoma.

Both J, Wu T, Ten Asbroek AL, Baas F, Hulsebos TJ.

Cytogenet Genome Res. 2016;150(1):52-59. doi: 10.1159/000451046. Epub 2016 Nov 16.

PMID:
27846620
6.

Infrequent but high-level amplification of 17p11.2 approximately p12 in human glioma.

van Dartel M, Leenstra S, Troost D, Hulsebos TJ.

Cancer Genet Cytogenet. 2003 Jan 15;140(2):162-6.

PMID:
12645656
7.

COPS3 amplification and clinical outcome in osteosarcoma.

Yan T, Wunder JS, Gokgoz N, Gill M, Eskandarian S, Parkes RK, Bull SB, Bell RS, Andrulis IL.

Cancer. 2007 May 1;109(9):1870-6.

8.

High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.

Squire JA, Pei J, Marrano P, Beheshti B, Bayani J, Lim G, Moldovan L, Zielenska M.

Genes Chromosomes Cancer. 2003 Nov;38(3):215-25.

PMID:
14506695
9.

Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma.

Fabris S, Todoerti K, Mosca L, Agnelli L, Intini D, Lionetti M, Guerneri S, Lambertenghi-Deliliers G, Bertoni F, Neri A.

Genes Chromosomes Cancer. 2007 Dec;46(12):1109-18.

PMID:
17823926
10.

Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.

Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, Ladanyi M, Gorlick R, Lau CC, Rao PH.

BMC Cancer. 2004 Aug 7;4:45.

11.

Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.

Selvarajah S, Yoshimoto M, Ludkovski O, Park PC, Bayani J, Thorner P, Maire G, Squire JA, Zielenska M.

Cytogenet Genome Res. 2008;122(1):5-15. doi: 10.1159/000151310. Epub 2008 Oct 14.

PMID:
18931480
12.

Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.

Willis S, Hutchins AM, Hammet F, Ciciulla J, Soo WK, White D, van der Spek P, Henderson MA, Gish K, Venter DJ, Armes JE.

Genes Chromosomes Cancer. 2003 Apr;36(4):382-92.

PMID:
12619162
13.

Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors.

Kanamori M, Sano A, Yasuda T, Hori T, Suzuki K.

J Exp Clin Cancer Res. 2012 Nov 30;31:100. doi: 10.1186/1756-9966-31-100.

14.

Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma.

Yen CC, Chen WM, Chen TH, Chen WY, Chen PC, Chiou HJ, Hung GY, Wu HT, Wei CJ, Shiau CY, Wu YC, Chao TC, Tzeng CH, Chen PM, Lin CH, Chen YJ, Fletcher JA.

Int J Oncol. 2009 Oct;35(4):775-88.

PMID:
19724913
15.

Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.

Both J, Krijgsman O, Bras J, Schaap GR, Baas F, Ylstra B, Hulsebos TJ.

PLoS One. 2014 Dec 31;9(12):e115835. doi: 10.1371/journal.pone.0115835. eCollection 2014.

16.

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma.

Lu XY, Lu Y, Zhao YJ, Jaeweon K, Kang J, Xiao-Nan L, Ge G, Meyer R, Perlaky L, Hicks J, Chintagumpala M, Cai WW, Ladanyi M, Gorlick R, Lau CC, Pati D, Sheldon M, Rao PH.

Mol Cancer Res. 2008 Jun;6(6):937-46. doi: 10.1158/1541-7786.MCR-07-2115.

17.

Isolation of osteosarcoma-associated amplified DNA sequences using representational difference analysis.

Simons A, Janssen IM, Suijkerbuijk RF, Veth RP, Pruszczynski M, Hulsbergen-van de Kaa CA, du Manoir S, Geurts van Kessel A.

Genes Chromosomes Cancer. 1997 Oct;20(2):196-200.

PMID:
9331570
18.

Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas.

Hulsebos TJ, Bijleveld EH, Oskam NT, Westerveld A, Leenstra S, Hogendoorn PC, Bras J.

Genes Chromosomes Cancer. 1997 Apr;18(4):279-85.

PMID:
9087567
19.

Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma.

Lau CC, Harris CP, Lu XY, Perlaky L, Gogineni S, Chintagumpala M, Hicks J, Johnson ME, Davino NA, Huvos AG, Meyers PA, Healy JH, Gorlick R, Rao PH.

Genes Chromosomes Cancer. 2004 Jan;39(1):11-21.

PMID:
14603437
20.

Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.

Bayani J, Zielenska M, Pandita A, Al-Romaih K, Karaskova J, Harrison K, Bridge JA, Sorensen P, Thorner P, Squire JA.

Genes Chromosomes Cancer. 2003 Jan;36(1):7-16.

PMID:
12461745

Supplemental Content

Support Center